This sponsor was hoping to expand its presence in inflammation and autoimmunity with four global, pivotal phase III protocols in patients with moderately-to-severely active rheumatoid arthritis.
This sponsor was hoping to expand its presence in inflammation and autoimmunity with four global, pivotal phase III protocols in patients with moderately-to-severely active rheumatoid arthritis.